IL-6 also appears to be a robust marker of both neuroinflammation and intracranial hypertension in the setting of TBI [149,150], and injection of anti-IL-6 antibodies reduced the production of pro-inflammatory cerebral cytokines and improved motor functions in mice [151]. Here, IL6 is linked to intracranial hypertension.